Advocacy on xylazine and adultered-opioid overdose solutions and federal funding.
Source-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 20, 2026
- Income
- $150,000.00
- Expenses
- Not reported
- Registrant
- STEPTOE LLP
- Client
- OREXO US, INC.
- Filing UUID
- b124ec6a-78a1-43e7-9c93-1d225c7f822d
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Advocacy on xylazine and adultered-opioid overdose solutions and federal funding.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.